Axiom Uniseal Part A

Hazard statements (CLP)

H226, H315, H319, H334, H373

Code

Statements

H226

Flammable liquid and vapour

SECTION 2: Hazards identification

Hazard statements

see section 16 : H226 - Flammable liquid and vapour H315 - Causes skin irritation H319 - Causes serious eye irritation H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H373 - May cause damage to organs through prolonged or repeated exposure

Adverse physicochemical, human health and environmental effects

No additional information available

2.2 Label elements

Labelling

Hazard pictograms

GHS02 GHS08

Signal word

Danger

Contains

Isocyanic acid, polymethylenepolyphenylene ester; Reaction mass of ethylbenzene and m- xylene and p-xylene; 4,4'- methylenediphenyl diisocyanate; diphenylmethane-4,4'- diisocyanate

Precautionary statements

P260 - Do not breathe vapours P280 - Wear protective gloves, face protection, eye protection P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P271 - Use only outdoors or in a well-ventilated area. P501 - Dispose of contents to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.

Supplemental label elements

EUH204 - Contains isocyanates. May produce an allergic reaction

Additional information

Persons already sensitised to diisocyanates may develop allergic reactions when using this product. Persons suffering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. As from 24 August 2023 adequate training is required before industrial or professional use.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %